Practice Areas

Whistleblower / False Claims Litigation

The impact of corporate wrongdoing is not limited to shareholders and private consumers. When corporate fraud impacts governments, federal and state False Claims Acts allow whistleblowers—acting in the name of the government—the right to seek redress against any company, entity or person. The Firm is committed to helping whistleblowers protect government interests under the qui tam provisions of the False Claims Act.

Counsel at G&E work with whistleblowers in all phases of the process, from initial meetings with government officials through the litigation process. Whistleblowers bringing suit under federal and state False Claims Act laws have enabled the government to recover more than $27 billion since 1986—the year that amendments were made to the federal False Claims Act, which ushered in a new era of fraud enforcement. These statutes generally allow the government to recover three times actual damages in addition to civil penalties for each invoice or false statement used to secure payment from the government. Whistleblowers who initiate false claims cases are entitled to a portion of the money recovered, or a bounty, generally ranging from 15 to 30% of the government’s total recovery. Since 1986, False Claims Act qui tam whistleblowers have been paid close to $3 billion in bounties.

Attorneys at G&E have represented whistleblowers in some of the largest and most successful cases brought under the False Claims Act, including cases involving:

  • Medicare & Medicaid Fraud
  • Pharmaceutical Fraud
  • Defense Contractor Fraud
  • Federal Government Contractor Fraud
  • Fraudulent Loans & Grants

View Representative Whistleblower/False Claims Cases

Helping whistleblowers protect government interests under the False Claims Act

$2.3 Billion Recovery
Pfizer
Whistleblower information led to this significant recovery for Federal and State governments
$1.6 Billion Recovery
Abbott Labs
One of the largest recoveries under the False Claims Act involving a single drug

Copyright © 2020 Grant & Eisenhofer P.A. All Rights Reserved.